Sunrise

Active

Public limited companyfounded 201511 yrs activeChaussée de Marche(EP) 598, 5101 Namur, BelgiumKBO/BCE: BE 0632.607.373

Summary

Sunrise has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €40.7m and a net result of -€2.6m. Equity is growing by ~106.6% per year across the filed fiscal years. Its solvency ranks better than 84% of 195 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysis Watch Report Compare

SunriseActiveChecked score 69/100

Risk analysis Report Compare

Checked score

Score 2025

69 / 100

Healthy

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability11▲+1

Solvency100=

Growth52=

Track record100

Bankruptcy probability, 12 months

0.3% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €2,000,000 at 30 days acceptable

Liquidity ample (current ratio 31.64 against 8.63 in 2024; short-term debt: 2.8% and cash: 9.3% of total assets), and 7.4% of the assets are financed with debt.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 72

Relative position

BE, all sectors

reference

Scientific research and development (NACE 72)

about 30% fewer bankruptcies

← fewer bankruptcies more bankruptcies →

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

92.6%

Return on assets

-6%

Age of the figures

9 mo

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

11 d early

2024

6 d early

2023

37 d early

2022

on the day

2021

23 d early

2020

37 d early

2019

11 d late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 15 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 20 July (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Position in the running window

29-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

History

Sunrise was incorporated on 20 June 2015 by two natural persons, with a starting capital of EUR 18,550.¹² The name was changed to Neoma Labs in 2017 and to Sunrise in 2019.³⁴ Between 2017 and 2025 the capital was increased 8 times, most recently to EUR 421,460.³⁵⁶ The registered office was moved to Erpent in 2021.⁷ The board currently has 11 members; KURMA DIAGNOSTICS 2 FPCI has served longest, since 2021.⁸ Total assets rose from EUR 527,901 in 2018 to EUR 44 million in 2025 and headcount from 4.3 to 15.9 full-time equivalents.⁹

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

In the rankings #2 company by total assets in the province of Namur, Research and development sector #2 company by equity in the province of Namur, Research and development sector #5 fastest grower in Namur, Professional and technical services sector

Turnover

Not included in this filing

EBIT margin

Not included in this filing

Net result

-€2.6m▼ 59.3%

2024 · -€1.7m

Working capital

€37.2m▲ 147%

2024 · €15.1m

Trend over the years

Chart Table

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before

favourable unfavourable

Line20212022202320242025

Operating result-€1.2m▼ 54.9%-€2.2m▼ 76.7%-€3.0m▼ 36.9%-€1.8m▲ 39.7%-€2.2m▼ 21.4%

Net result-€1.2m▼ 74.9%-€2.2m▼ 75.2%-€3.0m▼ 38.2%-€1.7m▲ 44.5%-€2.6m▼ 59.3%

Equity€3.6m▲ 227%€1.8m▼ 50.4%€12.5m▲ 607%€18.7m▲ 49.6%€40.7m▲ 118%

Total assets€4.6m▲ 183%€4.1m▼ 11.7%€16.4m▲ 300%€23.0m▲ 40.6%€43.9m▲ 91.0%

Debt€1.1m▲ 95.6%€2.3m▲ 117%€3.9m▲ 66.7%€4.2m▲ 8.6%€3.1m▼ 25.7%

Working capital€2.2m▲ 490%€226,021▼ 89.6%€10.7m▲ 4,629%€15.1m▲ 41.0%€37.2m▲ 147%

Solvency76.9%▲ 10.3pp43.2%▼ 33.7pp76.4%▲ 33.1pp81.3%▲ 4.9pp92.6%▲ 11.4pp

Current ratio4.11▲ 1.121.21▼ 2.9011.93▲ 10.728.63▼ 3.3031.64▲ 23.01

Return on assets (ROA)-26.6%▲ 16.5pp-52.8%▼ 26.2pp-18.2%▲ 34.6pp-7.2%▲ 11.0pp-6.0%▲ 1.2pp

Staff (FTE)7.1▲ 6.0%11.9▲ 67.6%14.5▲ 21.8%14.7▲ 1.4%15.9▲ 8.2%

above within below the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.

Result per fiscal year

Operating resultNet result

The operating result stays negative: a loss of €2.2m in 2025 against €1.8m in 2024; the loss grows.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €43.9m

12.5%

87.5%

Fixed assets €5.5m ▼ 7.2%

Current assets €38.4m ▲ 125%

Equity and liabilities €43.9m

92.6%

Equity €40.7m ▲ 118%

Provisions €110,000 =

Debt €3.1m ▼ 25.7%

Debt's share of the balance-sheet total falls from 18.3% to 7.1%. Equity is higher and debt is lower.

Key figures and ratios

2025 value · change against 2024

EBITDA

-€276,448▼

2024 · -€262,794

Cash flow

-€718,292▼

2024 · -€111,125

Quick ratio

31.43▲

2024 · 8.45

Debt to equity

0.08▼

2024 · 0.22

ROE

-6.5%▲

2024 · -8.9%

Interest coverage

-0.27▲

2024 · -2.63

Debt ≤ 1 year

€1.2m▼

2024 · €2.0m

Debt > 1 year

€1.9m▼

2024 · €2.0m

Income taxes

-€24,907▲

2024 · -€97,983

Staff costs

€3.3m▲

2024 · €2.9m

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,687 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 94% are still going.

Small
10 to 20 years old
solvency 30% or more
a small loss

0.6% went bankrupt

5.4% stopped otherwise

94% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	1.0%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.9%
9	3.0%	3.1%
10	5.6%	6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,687 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts

OverviewIncome statement Balance sheet Cash flow

Filed annual accounts As filed with the NBB · 2025 against 2024 · 66 lines

Balance sheet Code20242025

Assets

Total assets20/58€23.0m€43.9m▲

Formation expenses20€17,999€8,334▼

Fixed assets21/28€5.9m€5.5m▼

Intangible fixed assets21€5.7m€5.3m▼

Tangible fixed assets22/27€206,651€149,688▼

Plant, machinery and equipment23€101,994€71,643▼

Furniture and vehicles24€51,701€34,737▼

Other tangible fixed assets26€52,956€43,308▼

Financial fixed assets28€23,708€23,548▼

Current assets29/58€17.0m€38.4m▲

Stocks and contracts in progress3€365,985€257,848▼

Stocks30/36€365,985€257,848▼

Amounts receivable within one year40/41€8.5m€17.4m▲

Trade receivables40€2.4m€2.7m▲

Other amounts receivable41€6.1m€14.8m▲

Current investments50/53-€16.6m

Cash at bank and in hand54/58€8.1m€4.1m▼

Deferred charges and accrued income490/1€41,026€76,123▲

Equity and liabilities

Total equity and liabilities10/49€23.0m€43.9m▲

Equity10/15€18.7m€40.7m▲

Contributions10/11€23.9m€48.9m▲

Capital10€298,347€421,460▲

Issued capital100€298,347€421,460▲

Outside capital11€23.6m€48.5m▲

Share premium1100/10€23.6m€48.5m▲

Reserves13€20,805€20,805=

Non-distributable reserves130/1€11,205€11,205=

Legal reserve130€11,205€11,205=

Distributable reserves133€9,600€9,600=

Profit (loss) carried forward14-€8.2m-€10.8m▼

Investment grants15€2.9m€2.5m▼

Provisions and deferred taxes16€110,000€110,000=

Provisions for liabilities and charges160/5€110,000€110,000=

Other liabilities and charges164/5€110,000€110,000=

Amounts payable17/49€4.2m€3.1m▼

Amounts payable after more than one year17€2.0m€1.9m▼

Financial debts170/4€1.2m€872,500▼

Other amounts payable178/9€786,657€1.0m▲

Amounts payable within one year42/48€2.0m€1.2m▼

Current portion of amounts payable after more than one year42€281,160€465,265▲

Trade debts44€996,798€308,912▼

Suppliers440/4€996,798€308,912▼

Advances received on contracts in progress46€19,500-

Taxes, remuneration and social security45€369,666€439,087▲

Taxes450/3€21,063€71,525▲

Remuneration and social security454/9€348,603€367,562▲

Other amounts payable47/48€307,071€444▼

Accrued charges and deferred income492/3€255,533€19,076▼

Income statement Code20242025

Remuneration, social security and pensions62€2.9m€3.3m▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.5m€1.9m▲

Provisions for liabilities and charges: additions (uses and reversals)635/8€110,000-

Other operating charges640/8€3,314€27,096▲

Non-recurring operating charges66A€15-

Gross operating margin9900€2.7m€3.1m▲

Operating profit (loss)9901-€1.8m-€2.2m▼

Financial income75/76B€153,652€552,281▲

Recurring financial income75€153,652€552,281▲

Financial charges65/66B€99,966€1.0m▲

Recurring financial charges65€99,966€1.0m▲

Profit (loss) for the period before taxes9903-€1.8m-€2.7m▼

Income taxes67/77-€97,983-€24,907▲

Profit (loss) for the period9904-€1.7m-€2.6m▼

Profit (loss) for the period to be appropriated9905-€1.7m-€2.6m▼

Appropriation of the result

Profit (loss) to be appropriated9906-€8.2m-€10.8m▼

Profit (loss) brought forward from the previous period14P-€6.5m-€8.2m▼

Social balance

Average headcount (FTE)908714.715.9▲

The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line	2021	2022	2023	2024	2025	Change
Non-recurring operating income76A	-	-	€895	-	-	-
Remuneration, social security and pensions62	€698,729	€1.1m	€2.4m	€2.9m	€3.3m	▲ 14.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630	€381,130	€802,281	€1.1m	€1.5m	€1.9m	▲ 24.2%
Provisions for liabilities and charges: additions (uses and reversals)635/8	-	-	-	€110,000	-	-
Other operating charges640/8	€961	€1,808	€6,685	€3,314	€27,096	▲ 718%
Non-recurring operating charges66A	€615,959	-	€59,996	€15	-	-
Gross operating margin9900	€457,775	-€278,308	€566,727	€2.7m	€3.1m	▲ 12.0%
Operating profit (loss)9901	-€1.2m	-€2.2m	-€3.0m	-€1.8m	-€2.2m	▼ 21.4%
Financial income75/76B	€1,729	€2,107	€8,100	€153,652	€552,281	▲ 259%
Recurring financial income75	€1,729	€2,107	€8,100	€153,652	€552,281	▲ 259%
Financial charges65/66B	€25,309	€28,286	€130,627	€99,966	€1.0m	▲ 919%
Recurring financial charges65	€25,309	€28,286	€130,627	€99,966	€1.0m	▲ 919%
Profit (loss) for the period before taxes9903	-€1.3m	-€2.2m	-€3.1m	-€1.8m	-€2.7m	▼ 51.8%
Income taxes67/77	-€31,529	-€58,636	-€138,811	-€97,983	-€24,907	▲ 74.6%
Profit (loss) for the period9904	-€1.2m	-€2.2m	-€3.0m	-€1.7m	-€2.6m	▼ 59.3%
Profit (loss) for the period to be appropriated9905	-€1.2m	-€2.2m	-€3.0m	-€1.7m	-€2.6m	▼ 59.3%

Line	2021	2022	2023	2024	2025	Change
Assets
Total assets20/58	€4.6m	€4.1m	€16.4m	€23.0m	€43.9m	▲ 91.0%
Formation expenses20	€46,994	€37,329	€27,664	€17,999	€8,334	▼ 53.7%
Fixed assets21/28	€1.7m	€2.7m	€4.7m	€5.9m	€5.5m	▼ 7.2%
Intangible fixed assets21	€1.6m	€2.6m	€4.4m	€5.7m	€5.3m	▼ 6.5%
Tangible fixed assets22/27	€85,703	€93,991	€259,063	€206,651	€149,688	▼ 27.6%
Plant, machinery and equipment23	€2,316	-	€132,345	€101,994	€71,643	▼ 29.8%
Furniture and vehicles24	€8,858	€21,739	€64,114	€51,701	€34,737	▼ 32.8%
Other tangible fixed assets26	€74,528	€72,251	€62,604	€52,956	€43,308	▼ 18.2%
Financial fixed assets28	€610	€5,110	€11,090	€23,708	€23,548	▼ 0.7%
Current assets29/58	€2.9m	€1.3m	€11.7m	€17.0m	€38.4m	▲ 125%
Stocks and contracts in progress3	€173,953	€228,537	€524,852	€365,985	€257,848	▼ 29.5%
Stocks30/36	€173,953	€228,537	€524,852	€365,985	€257,848	▼ 29.5%
Amounts receivable within one year40/41	€158,737	€765,648	€3.6m	€8.5m	€17.4m	▲ 105%
Trade receivables40	€74,092	€114,651	€689,363	€2.4m	€2.7m	▲ 11.5%
Other amounts receivable41	€84,645	€650,997	€2.9m	€6.1m	€14.8m	▲ 142%
Current investments50/53	-	-	-	-	€16.6m	-
Cash at bank and in hand54/58	€2.4m	€300,843	€7.5m	€8.1m	€4.1m	▼ 50.0%
Deferred charges and accrued income490/1	€96,921	€22,491	€34,445	€41,026	€76,123	▲ 85.6%
Equity and liabilities
Total equity and liabilities10/49	€4.6m	€4.1m	€16.4m	€23.0m	€43.9m	▲ 91.0%
Equity10/15	€3.6m	€1.8m	€12.5m	€18.7m	€40.7m	▲ 118%
Contributions10/11	€4.1m	€4.1m	€16.8m	€23.9m	€48.9m	▲ 105%
Capital10	€190,904	€190,904	€259,655	€298,347	€421,460	▲ 41.3%
Issued capital100	€190,904	€190,904	€259,655	€298,347	€421,460	▲ 41.3%
Outside capital11	€3.9m	€3.9m	€16.5m	€23.6m	€48.5m	▲ 105%
Share premium1100/10	€3.9m	€3.9m	€16.5m	€23.6m	€48.5m	▲ 105%
Reserves13	€20,805	€20,805	€20,805	€20,805	€20,805	=
Non-distributable reserves130/1	€11,205	€11,205	€11,205	€11,205	€11,205	=
Legal reserve130	€11,205	€11,205	€11,205	€11,205	€11,205	=
Distributable reserves133	€9,600	€9,600	€9,600	€9,600	€9,600	=
Profit (loss) carried forward14	-€1.4m	-€3.5m	-€6.5m	-€8.2m	-€10.8m	▼ 32.2%
Investment grants15	€810,644	€1.2m	€2.2m	€2.9m	€2.5m	▼ 13.8%
Provisions and deferred taxes16	-	-	-	€110,000	€110,000	=
Provisions for liabilities and charges160/5	-	-	-	€110,000	€110,000	=
Other liabilities and charges164/5	-	-	-	€110,000	€110,000	=
Amounts payable17/49	€1.1m	€2.3m	€3.9m	€4.2m	€3.1m	▼ 25.7%
Amounts payable after more than one year17	€366,382	€1.2m	€2.9m	€2.0m	€1.9m	▼ 4.1%
Financial debts170/4	€212,500	€162,500	€1.4m	€1.2m	€872,500	▼ 26.2%
Other amounts payable178/9	€153,882	€1.1m	€1.4m	€786,657	€1.0m	▲ 29.1%
Amounts payable within one year42/48	€698,638	€1.1m	€977,828	€2.0m	€1.2m	▼ 38.5%
Current portion of amounts payable after more than one year42	€127,500	€95,000	€88,571	€281,160	€465,265	▲ 65.5%
Trade debts44	€246,126	€676,300	€531,622	€996,798	€308,912	▼ 69.0%
Suppliers440/4	€246,126	€676,300	€531,622	€996,798	€308,912	▼ 69.0%
Advances received on contracts in progress46	-	€97,500	€39,000	€19,500	-	-
Taxes, remuneration and social security45	€93,521	€221,816	€305,326	€369,666	€439,087	▲ 18.8%
Taxes450/3	€10,725	€17,179	€35,881	€21,063	€71,525	▲ 240%
Remuneration and social security454/9	€82,796	€204,637	€269,445	€348,603	€367,562	▲ 5.4%
Other amounts payable47/48	€231,491	€880	€13,311	€307,071	€444	▼ 99.9%
Accrued charges and deferred income492/3	€2,610	€1,418	€36,317	€255,533	€19,076	▼ 92.5%

Line	2021	2022	2023	2024	2025	Change
Profit (loss) for the period9904	-€1.2m	-€2.2m	-€3.0m	-€1.7m	-€2.6m	▼ 59.3%
+ Depreciation and write-downs630	€381,130	€802,281	€1.1m	€1.5m	€1.9m	▲ 24.2%
Operating cash flow (approximation)	-€849,925	-€1.4m	-€1.9m	-€111,125	-€718,292	▼ 546%
Investment in fixed assets (approximation)	-	-€1.8m	-€3.1m	-€2.8m	-€1.5m	▲ 47.1%
Change in cash	-	-€2.1m	€7.2m	€637,995	-€4.1m	▼ 739%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

All 38Financial 11Gazette 17Filings 10

Next filing, fiscal year 2026, expected by 31-07-2027

2026

08-09

State Gazette act Resignation: Maxime HUERRE (director)

Appointment: EURAZEO GLOBAL INVESTOR SAS (director) · Permanent representative: Maxime HUERRE3 facts ▸

Director resignation, Maxime HUERRE (director)
Director appointment, EURAZEO GLOBAL INVESTOR SAS (director)
Permanent representative, Maxime HUERRE (permanent representative)

20-07

NBB filing Annual accounts filed

fiscal year 2025 · full schema

2025

31-12

Financial Liquidity quadruplescurrent ratio 31.64

Current ratio from 8.63 to 31.64; short-term debt falls from €2.0m to €1.2m.

31-12

Financial Equity above €25mEq €40.7m ▲118%

Equity rises from €18.7m to €40.7m.

17-11

State Gazette act Capital & shares · Statutes amendment

Share cancellation · Capital increase · Bank account7 facts ▸

General meeting, 05-11-2025
Share cancellation, Droits de Souscription ESOP, 171316
Capital increase, €1.130
Bank account, BE45 0020 1793 8789
Capital, €421.459,88
Share issue, Droits de Souscription, 3061865
Power of attorney, Organe d'administration de SUNRISE

05-08

State Gazette act Resignations: MARTINOT Laurent François Yves, MARTINOT Pierre Antoine Benoît and 2 others

Appointments: MARTINOT Laurent François Yves, MARTINOT Pierre Antoine Benoît and 6 others · Permanent representatives: PELTIER Philippe and VANCOPPENOLLE Yannick Luc Georges · Capital increase28 facts ▸

General meeting, 22-07-2025
Capital increase, €121.982,94
Share issue, droits de souscription anti-dilutifs « juillet 2025 », 21
Share issue, droits de souscription d'indemnisation, 21
Statutes amendment
Share conversion, 647701, Actions Préférentielles de Classe B'
Statutes amendment
Capital, €420.329,88
Director resignation, MARTINOT Laurent François Yves (director)
Director resignation, MARTINOT Pierre Antoine Benoît (director)
Director resignation, Kurma Partners (director)
Director resignation, VIVES Partners (director)
+16 further facts in this act

25-07

NBB filing Annual accounts filed

fiscal year 2024 · full schema

2024

06-08

State Gazette act Reappointment: Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL (statutory auditor)

2 facts ▸

General meeting, 07-06-2024
Auditor reappointment, Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL

15-07

State Gazette act Capital & shares · Statutes amendment

Capital increase · Capital · Power of attorney7 facts ▸

Capital increase, €142,38
Capital increase, €38.549,21
Capital, €298.346,94
Statutes amendment
Power of attorney, Hadrien Chef
Power of attorney, Violette Keppenne
Power of attorney, Mathilde Drion

24-06

NBB filing Annual accounts filed

fiscal year 2023 · full schema

26-03

State Gazette act Resignation: Sopartec SA (director)

Appointment: Vives Partners SRL (director) · Permanent representative: Yannick VANCOPPENOLLE · Mandate compensation6 facts ▸

Board meeting, 28-02-2024
Director resignation, Sopartec SA (director)
Director appointment, Vives Partners SRL (director)
Permanent representative, Yannick VANCOPPENOLLE
Permanent representative, Yannick VANCOPPENOLLE
Mandate compensation, Vives Partners SRL

2023

31-12

Financial Weakest financial yearnet -€3.0m

Net result drops to -€3.0m, the lowest in the series; recovery starts the following year.

Show earlier events

31-12

Financial Liquidity times 10current ratio 11.93

Current ratio from 1.21 to 11.93; short-term debt falls from €1.1m to €977,828.

31-12

Financial Equity above €10mEq €12.5m ▲607%

Equity rises from €1.8m to €12.5m.

08-08

State Gazette act Capital & shares · Statutes amendment

Capital increase · Bank account · Share issue6 facts ▸

General meeting, 31-07-2023
Capital increase, €21.286,75
Bank account, compte spécial au nom de la Société, auprès de BNP Paribas Fortis
Capital increase
Share issue, anti-dilutive_subscription_rights, 7
Capital, €251.525,46

31-07

NBB filing Annual accounts filed

fiscal year 2022 · full schema

15-03

State Gazette act Capital & shares · Statutes amendment

Capital · Capital increase · Share issue15 facts ▸

General meeting, 02-03-2023
Capital, €230.238,71
Capital increase, €39.335,05
Share issue, droits de souscription anti-dilutifs, 12
Share issue, droits de souscription ESOP, 1402917
Statutes amendment
Share split, 100, 2142600
Share class creation, Actions Préférentielles de Classe B
Rights modification, droits de souscription ESOP, Actions Ordinaires
Rights modification, droits de souscription anti-dilutifs, EUR
Conditional capital increase, EUR, 30-06-2024
Conditional capital increase, exercice des droits de souscription anti-dilutifs, Actions Préférentielles de Classe B
+3 further facts in this act

2022

08-07

NBB filing Annual accounts filed

fiscal year 2021 · full schema

2021

31-12

Financial Equity above €2mEq €3.6m ▲227%

Equity rises from €1.1m to €3.6m.

13-12

State Gazette act Resignation: van RIJCKEVORSEL Laure Philippine Louise Ghislaine Marie (director)

Appointments: MARTINOT Laurent, MARTINOT Pierre and 3 others · Permanent representatives: PELTIER Philippe and VANCOPPENOLLE Yannick Luc Georges · Capital increase22 facts ▸

General meeting, 26-11-2021
Capital increase, €54.642,28
Share issue, Actions Préférentielles de Classe A, 48356
Share issue, droits de souscription anti-dilutifs, 4
Capital, €190.903,66
Director resignation, van RIJCKEVORSEL Laure Philippine Louise Ghislaine Marie (director)
Director appointment, MARTINOT Laurent (director)
Director appointment, MARTINOT Pierre (director)
Director appointment, KURMA DIAGNOSTICS 2 FPCI (director)
Permanent representative, PELTIER Philippe
Director appointment, SOPARTEC (director)
Permanent representative, VANCOPPENOLLE Yannick Luc Georges
+10 further facts in this act

16-08

State Gazette act Registered office

Registered-office move2 facts ▸

Board meeting, 29/07/2021
Registered-office move, Chaussée de Marche, 598 à 5101 Erpent

11-08

State Gazette act Resignation: Pierre RIGAUX (director)

Appointment: Laure VAN RIJCKEVORSEL (director)3 facts ▸

General meeting, 04-06-2021
Director resignation, Pierre RIGAUX (director)
Director appointment, Laure VAN RIJCKEVORSEL (director)

24-06

NBB filing Annual accounts filed

fiscal year 2020 · full schema

2020

31-12

Financial Liquidity doublescurrent ratio 2.99

Current ratio from 1.35 to 2.99.

31-12

Financial Equity above €1mEq €1.1m ▲59.4%

Equity rises from €682,733 to €1.1m.

22-12

State Gazette act Appointment: Pierre RIGAUX (director)

Resignation: Laure VAN RIJCKEVORSEL (director) · Director discharge4 facts ▸

General meeting, 29-10-2020
Director appointment, Pierre RIGAUX (director)
Director resignation, Laure VAN RIJCKEVORSEL (director)
Director discharge, Laure VAN RIJCKEVORSEL

02-09

State Gazette act Capital & shares

Share issue2 facts ▸

General meeting, 29-07-2020
Share issue, Emission de droits de souscription

11-08

NBB filing Annual accounts filed

fiscal year 2019 · full schema · 11 days late

18-02

State Gazette act Appointment: VAN RIJCKEVORSEL Laure Philippine Louise Ghislaine Marie (director)

Legal-form conversion · Net-asset statement · Share issue13 facts ▸

General meeting, 05-02-2020
Legal-form conversion, Société à responsabilité limitée -> Société anonyme
Net-asset statement, 31-12-2019
Share issue, scission, 100000
Capital increase, €24.211,38
Bank account, BE78 0018 7546 4886
Capital, €136.261,38
Director appointment, VAN RIJCKEVORSEL Laure Philippine Louise Ghislaine Marie (director)
Board composition, MARTINOT Laurent François Yves (director)
Board composition, MARTINOT Pierre Antoine Benoît (director)
Mandate compensation, VAN RIJCKEVORSEL Laure Philippine Louise Ghislaine Marie
Power of attorney, Van De Kerckhove Laura
+1 further facts in this act

2019

31-12

Financial Highest result since 2018net €452,372 ▲635%

Operating result €453,197, net result €452,372, both a record.

31-12

Financial Liquidity quadruplescurrent ratio 1.35

Current ratio from 0.33 to 1.35; short-term debt falls from €297,541 to €165,718.

31-12

Financial Equity above €500,000Eq €682,733 ▲196%

2 profitable years in a row build equity to €682,733.

26-08

NBB filing Annual accounts filed

fiscal year 2018 · full schema · 26 days late

30-01

State Gazette act Resignations & appointments

Name change · Statutes amendment2 facts ▸

Name change, Sunrise
Statutes amendment

2018

12-07

NBB filing Annual accounts filed

fiscal year 2017 · full schema

2017

18-08

NBB filing Annual accounts filed

fiscal year 2016 · full schema · 18 days late

03-04

State Gazette act Appointment: Laurent MARTINOT (non-statutory manager)

Name change · Capital increase · Capital5 facts ▸

Name change, Neoma Labs
Capital increase, €93.500
Capital, €112.050
Statutes amendment
Director appointment, Laurent MARTINOT (non-statutory manager)

2015

24-06

State Gazette act Incorporation

Appointment: MARTINOT Pierre Antoine Benoît (non-statutory manager) · Founding capital · Mandate compensation9 facts ▸

Incorporation, 18-06-2015
Founding capital, €18.550
Director appointment, MARTINOT Pierre Antoine Benoît (non-statutory manager)
Mandate compensation, MARTINOT Pierre Antoine Benoît
Capital liberation, 700/1855, 7000
Founder, MARTINOT Pierre Antoine Benoît
Founder, MARTINOT Cédric Quentin Alex
Assumption of liabilities, Tous les engagements ainsi que les obligations qui en résultent, et toutes les activités entreprises depuis le premier janvier 2015 par l'un ou l'autre des comp…
No commissaire, les comparants décident de ne pas procéder actuellement à la nomination d'un commissaire

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

17 of 17 acts read

Directors · office · real estate

Directors

8 directors, 2 in day-to-day management, no change since 2025

Board 8

KURMA DIAGNOSTICS 2 FPCI

Director · since 26-11-2021 · Legal entity · perm. rep.: PELTIER Philippe

Current

VIVES PARTNERS

Director · since 30-01-2024 · Private limited company · perm. rep.: Yannick VANCOPPENOLLE

Current

EURAZEO GLOBAL INVESTOR SAS

Director · since 22-07-2025 · Legal entity · perm. rep.: Maxime HUERRE

Current

HUERRE Maxime

Director · since 22-07-2025

Current

Kurma Partners

Director · since 22-07-2025 · Legal entity · perm. rep.: PELTIER Philippe

Current

MARTINOT Laurent François Yves

Director · since 22-07-2025

Current

MARTINOT Pierre Antoine Benoît

Director · since 22-07-2025

Current

VIVES Partners

Director · since 22-07-2025 · Legal entity · perm. rep.: VANCOPPENOLLE Yannick Luc Georges

Current

Day-to-day management 2

MARTINOT Laurent François Yves

Managing director · since 26-11-2021

Current

MARTINOT Pierre Antoine Benoît

Managing director · since 26-11-2021

Current

Permanent representatives 3

Maxime HUERRE

Permanent representative · since 22-07-2025 · for EURAZEO GLOBAL INVESTOR SAS

Current

PELTIER Philippe

Permanent representative · since 22-07-2025 · for Kurma Partners

Current

VANCOPPENOLLE Yannick Luc Georges

Permanent representative · since 22-07-2025 · for VIVES Partners

Current

Statutory auditor 1

Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises

Auditor · since 26-11-2021

Current

Other functions 3

FACKELMANN Surya

Observateur · since 22-07-2025

Current

LE TONNELIER DE BRETEUIL Pauline

Observateur · since 22-07-2025

Current

Nicolas DELAHAYE

Observateur · since 22-07-2025

Current

Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →

Location & real-estate footprint

Registered office, Namur · 1 establishment unit since 2015

seat establishment The establishment unit on the map

Ground area

2,522 m²

Building footprint

1,027 m²

Parcel 92039B0032/00Z002, Wallonia. Linked by address, not a title deed.

1 establishment unit

SUNRISE

Chaussée de Marche(EP) 598, 5101 NamurManufacture of computer, electronic and optical products

since 20152.242.912.390

1 parcel

Wallonia 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
92039B0032/00Z002	Wallonia	2,522 m²	1 · 1,027 m²	-

Linked by address, not proof of ownership

Good to know

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Mandate history

15 people since 2015, 12 in office

All 15 In office 12 Ended 3

Board
Day-to-day management
Statutory auditor
Other function
began earlier

Mandates per person, with start and end dates
Name	Functions and periods
MARTINOT Pierre Antoine Benoît	Non-statutory manager, from 18-06-2015 to 22-07-2025 Daily management delegate, from 26-11-2021 to date Director, from 22-07-2025 to date
MARTINOT Laurent François Yves	Non-statutory manager, from 15-03-2017 to 22-07-2025 Daily management delegate, from 26-11-2021 to date Director, from 22-07-2025 to date
KURMA DIAGNOSTICS 2 FPCI	Director, from 26-11-2021 to date
VIVES PARTNERS	Director, from 30-01-2024 to date
EURAZEO GLOBAL INVESTOR SAS	Director, from 22-07-2025 to date
HUERRE Maxime	Director, already before 22-07-2025 to date
Kurma Partners	Director, already before 22-07-2025 to date
VIVES Partners	Director, already before 22-07-2025 to date
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises	Auditor, from 26-11-2021 to date
FACKELMANN Surya	Observateur, from 22-07-2025 to date
LE TONNELIER DE BRETEUIL Pauline	Observateur, from 22-07-2025 to date
Nicolas DELAHAYE	Observateur, from 22-07-2025 to date
SOPARTEC	Director, from 26-11-2021 to 30-01-2024
van RIJCKEVORSEL Laure Philippine Louise Ghislaine Marie	Director, from 05-02-2020 to 29-10-2020 Director, from 03-05-2021 to 26-11-2021
Pierre RIGAUX	Director, from 29-10-2020 to 02-05-2021

Show all 15 people Show the first 12See the board, name and seat on a given date →

Articles of association

Purpose

Toutes opérations se rapportant directement ou indirectement aux activités suivantes : dans le secteur de la santé et plus particulièrement le domaine médical, paramédical et…

Full purpose

Toutes opérations se rapportant directement ou indirectement aux activités suivantes : dans le secteur de la santé et plus particulièrement le domaine médical, paramédical et pharmacologique, le développement de matériel électronique et logiciels sans limite aucune ou de toute autre technologie à visée thérapeutique ou diagnostique ; fournir des prestations de services divers dans le domaine de la santé... ; permettre aux médecins légalement habilités de pratiquer une médecine de qualité... ; La société pourra d'une façon générale accomplir toutes opérations commerciales, industrielles, financières, mobilières ou immobilières se rapportant directement ou indirectement à son objet...

according to the deed of 05-08-2025

Power of attorney

One provision in the deed

according to the deed of 08-09-2026

Structure & network

Owners and holdings

3 owners · 1 holding

Owners 3

Vives Inter-University Fund

Sourceaccounts Vives Inter-University Fund 2024

6.88%
INVESTSUD

Sourceaccounts INVESTSUD 2025

1.93%
SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON

Sourceaccounts SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON 2025

0.72%

Holdings 1

SUNRISE IncorporatedUSsubsidiary

Sourceown accounts 2025
Equity -USD 4.2mResult -USD 4.2m

100%

According to the 2025 annual accounts of Sunrise and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

15 connected companies

Depth

Shared directors

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Linked via shared directors

NAMUR INVEST

via Nicolas DELAHAYE · Permanent representative

→

ECONOMISCH HUIS OOSTENDE

via Nicolas DELAHAYE · Director

former→

AQYLA BioVenture Builder

Shared corporate director

→

BOTALYS

Shared corporate director

→

Show 11 more companies with a shared director

BRUSSELS LIFE SCIENCE INCUBATOR

Shared corporate director

→

CISSOID

Shared corporate director

→

intoPIX

Shared corporate director

→

iTeos Belgium

Shared corporate director

→

n-Side

Shared corporate director

→

NOVADIP BIOSCIENCES

Shared corporate director

→

REACFIN

Shared corporate director

→

SiPulse

Shared corporate director

→

The Akkermansia Company

Shared corporate director

→

ViroVet

Shared corporate director

→

VIVES II - Louvain Technology Fund

Shared corporate director

→

Capital and shareholders

Shareholders according to the acts

After the capital increase act of 18-02-2020 ↗

MARTINOT Pierre Antoine Benoît 7,142 shares
MARTINOT Laurent François Yves 7,142 shares
FPCI Secret Fund 7,142 shares

At incorporation act of 24-06-2015 ↗

MARTINOT Pierre Antoine Benoît founder
MARTINOT Cédric Quentin Alex founder

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years

17-11-2025 Capital increase of 1,130 EUR · to 421,459.88 EUR · 100,000 new shares
05-08-2025 Capital increase of 121,982.94 EUR · to 420,329.88 EUR · 10,794,950 new shares
15-07-2024 Capital increase of 142.38 EUR · to 259,797.73 EUR · 12,600 new shares
15-07-2024 Capital increase of 38,549.21 EUR · to 298,346.94 EUR · 3,411,434 new shares
08-08-2023 Capital increase of 21,286.75 EUR · to 251,525.46 EUR · 1,883,783 new shares
15-03-2023 Capital increase of 39,335.05 EUR · to 230,238.71 EUR · 3,480,978 new shares
13-12-2021 Capital increase of 54,642.28 EUR · to 190,903.66 EUR · 48,356 new shares
18-02-2020 Capital increase of 24,211.38 EUR · to 136,261.38 EUR · 21,426 new shares

Show 2 older capital entries

03-04-2017 Capital increase of 93,500 EUR · to 112,050 EUR · in cash
24-06-2015 Incorporation · 18,550 EUR · 100 shares

Public money · subsidies and aid

European Union, budget

2022 · 2 entries · 1,939,875 EUR in total

Year	Entries	awarded
2022	2	1,939,875 EUR

Projects

SUNRISE TX - EIISA A CONNECTED, AFFORDABLE LIGHT SOLUTION FOR TREATING SLEEP APNEA.

Horizon Europe · 01-07-2022 to 30-06-2024 · 1,939,875 EUR

European research

2 projects · 2 as coordinator · 1,989,875 EUR EU contribution

Programmes

Horizon Europe

1 entry · 1,939,875 EUR

Horizon 2020

1 entry · 50,000 EUR

Projects

EIisa –a connected, affordable light solution for treating sleep apnea.

Horizon Europe · coordinator · 01-07-2022 to 31-12-2024 · 1,939,875 EUR · SUNRISE Tx

Effortlessly Diagnosing Sleep Apnea with the Sensa Platform

Horizon 2020 · coordinator · 01-04-2018 to 30-09-2018 · 50,000 EUR · Sensa

Similar companies · same sector, comparable size

NATAGORA

BE 0434.366.097

Namur · Eq €44.4m

Instituut voor Tropische Geneeskunde

BE 0410.057.701

Antwerpen · Eq €36.2m

Inagro, provinciaal extern verzelfstandigd agentschap in privaatrechtelijke vorm

BE 0417.474.241

Roeselare · Eq €33.5m

Confo Therapeutics

BE 0632.474.939

Gent · Eq €33.3m

INEOS SERVICES BELGIUM

BE 0871.521.046

Brussel · Eq €50.4m

Of 1,177 companies in sector 72109 we hold annual accounts for 717. 103 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification

Legal formPublic limited company

Founded20-06-2015

Fiscal year end31-12

Activities, NACEBEL 2025

26600Manufacture of computer, electronic and optical products

72109Other research and development on natural sciences

46460Wholesale of pharmaceutical and medical goods

74999Other professional, scientific and technical activities

77225Rental and leasing activities

82990Other business support services

Contact

E-mail hello@sunrise.comNamur

Phone +3281261126Namur

E-invoicing

Reachable via Peppol

Peppol ID 0208:0632607373

If you follow this company, Checked tells you the day it leaves the Peppol register.

Scores and ratios are computed by Checked and are not a credit decision.